Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model

References

• Chang CW, Wu KB, Huang ZM, Chen CH. Prevalence of influenza virsus between Taiwan and other contries (in Chinese). Taiwan Epidemiol Bull 2006; 22:813-27.
   Google Scholar
• World Health Organization. Vaccine use. 2013.
   Google Scholar
• National Health Insurance Administration. Catastrophic Illness definition of National Health Insurance. 2011.
   Google Scholar
• Lee PI. Influenza Vaccine. Taipei, Taiwan: Centers for Disease Control, Department of Health, R.O.C (Taiwan); 2011.
   Google Scholar
• Centers for Disease Control and Prevention. Seasonal influenza activity surveillance reports: 1999–2000 to 2010–2011 seasons. Atlanta, USA.
   Google Scholar
• Chang C-W, Chuang R-H, Wu K-B. Epidemiological Analysis of Seasonal Influenza Epidemic in Taiwan in 2006/2007. Epidemiol Bull 2008; 24:876-89.
   Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; http://dx.doi.org/10.1016/j.vaccine.2011.12.098
   PubMed Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Willig AM. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 2012; 30:7443-6; PMID:23084849; http://dx.doi.org/10.1016/j.vaccine.2012.10.025
   PubMed Web of Science ®Google Scholar
• Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006; 24:4934-41; PMID:16678945; http://dx.doi.org/10.1016/j.vaccine.2006.03.057
   PubMed Web of Science ®Google Scholar
• Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, Nicholson KG. The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age. Vaccine 2006; 24:1035-43; PMID:16183177; http://dx.doi.org/10.1016/j.vaccine.2004.12.033
   PubMed Web of Science ®Google Scholar
• Newall AT, Scuffham PA, Kelly H, Harsley S, MacIntyre CR. The cost-effectiveness of a universal influenza vaccination program for adults aged 50–64 years in Australia. Vaccine 2008; 26:2142-53; PMID:18343537; http://dx.doi.org/10.1016/j.vaccine.2008.01.050
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: Cost-effectiveness of rapid testing and antiviral therapy. Annal Int Med 2003; 139:321-9; http://dx.doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00007
   PubMed Web of Science ®Google Scholar
• Hoshi SL, Kondo M, Honda Y, Okubo I. Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan. Vaccine 2007; 25:6511-21; PMID:17681651; http://dx.doi.org/10.1016/j.vaccine.2007.05.067
   PubMed Web of Science ®Google Scholar
• Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics 2004; 13:437-52; PMID:15127424; http://dx.doi.org/10.1002/hec.864
   PubMed Web of Science ®Google Scholar
• George B, Harris A, Mitchell A. Cost effectiveness analysis and the consistency of decision making - Evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics 2001; 19:1103-9; PMID:11735677; http://dx.doi.org/10.2165/00019053-200119110-00004
   PubMed Web of Science ®Google Scholar
• Bridges JFP, Onukwugha E, Mullins CD. Healthcare Rationing by Proxy Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the US. Pharmacoeconomics 2010; 28:175-84; PMID:20067332; http://dx.doi.org/10.2165/11530650-000000000-00000
   PubMed Web of Science ®Google Scholar
• Van Bellinghen LA, Meier G, Van Vlaenderen I. The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model. Plos One 2014; 9:e98437; PMID:24905235; http://dx.doi.org/10.1371/journal.pone.0098437
   PubMed Web of Science ®Google Scholar
• Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunotherap 2014; 10:1171-80; http://dx.doi.org/10.4161/hv.28221
   PubMed Web of Science ®Google Scholar
• You JHS, Ming WK, Chan PKS. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis. Hum Vaccin Immunotherap 2015; 11:564-71; http://dx.doi.org/10.1080/21645515.2015.1011016
   PubMed Web of Science ®Google Scholar
• Chit A, Roiz J, Aballea S. An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada Using a static model. Plos One 2015; 10:e0133606; PMID:26222538; http://dx.doi.org/10.1371/journal.pone.0133606
   PubMed Web of Science ®Google Scholar
• Meier G, Gregg M, Nautrup BP. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK. J Med Econom 2015; 18:746-61; http://dx.doi.org/10.3111/13696998.2015.1044456
   PubMed Web of Science ®Google Scholar
• You JHS, Ming WK, Chan PK. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong. BMC Infect Dis 2014; 14:618; http://dx.doi.org/10.1186/s12879-014-0618-9
   Web of Science ®Google Scholar
• Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technol Assess 2009; 13:1-+; PMID:19215705; http://dx.doi.org/10.3310/hta13110
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. The public poll of avian influenza immunization. e-Society Research Group 2005.
   Google Scholar
• Lin JH, Chiu SC, Shaw MW, Lin YC, Lee CH, Chen HY, Klimov A. Characterization of the epidemic influenza B viruses isolated during 2004–2005 season in Taiwan. Virus Res 2007; 124:204-11; PMID:17196288; http://dx.doi.org/10.1016/j.virusres.2006.11.005
   PubMed Web of Science ®Google Scholar
• Lo YC, Chuang JH, Kuo HW, Huang WT, Hsu YF, Liu MT, Chen CH, Huang HH, Chang CH, Chou JH, et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011–12 season. PLoS One 2013; 8:e58222; PMID:23472161; http://dx.doi.org/10.1371/journal.pone.0058222
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2010:CD004876.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews 2008:CD004879.
   PubMed Web of Science ®Google Scholar
• Chuang JH, Huang AS, Huang WT, Liu MT, Chou JH, Chang FY, Chiu WT. Nationwide surveillance of influenza during the pandemic (2009–10) and post-pandemic (2010–11) periods in Taiwan. PLoS One 2012; 7:e36120; PMID:22545158; http://dx.doi.org/10.1371/journal.pone.0036120
   PubMed Web of Science ®Google Scholar
• Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003; 7:iii-iv, xi-xiii, 1-170; PMID:14609480; http://dx.doi.org/10.3310/hta7350
   PubMedGoogle Scholar
• Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19:834-42; PMID:11152308; http://dx.doi.org/10.1007/s100960000376
   PubMed Web of Science ®Google Scholar
• Chuang JH, Cheng-Hua Lee P-IL, Wu CF, Liu M-T, Su WY, Huang WT. Effectiveness of influenza A (H1N1) monovalent vaccine and trivalent inactivated influenza vaccine. Centers for Disease and Control, R.O.C. (Taiwan), 2010.
   Google Scholar
• Centers for Disease Control. Practical guideline for prevention and control of seasonal influenza (in Chinese). Taipei City, Taiwan (R.O.C.): Centers of Disease and Control, Department of Health, 2008.
   Google Scholar
• Griffin AD, Perry AS, Fleming DM. Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients. PharmacoEconomics 2001; 19:293-301; PMID:11303417; http://dx.doi.org/10.2165/00019053-200119030-00007
   PubMed Web of Science ®Google Scholar
• Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. Bmc Health Serv Res 2006; 6:52; PMID:16623946
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Db Syst Rev 2008.
   Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Db Syst Rev 2010.
   Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2010; CD001269
   Web of Science ®Google Scholar
• Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013; 11:153; PMID:23800265; http://dx.doi.org/10.1186/1741-7015-11-153
   PubMed Web of Science ®Google Scholar
• Gagliardi L, Rusconi F, Galassi C, Forastiere F. Re.: “Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children”. Am J Epidemiol 2011; 173:1343; author reply 4–5; PMID:21478296; http://dx.doi.org/10.1093/aje/kwr082
   PubMed Web of Science ®Google Scholar